Peter F. Lang
Director of Finance/CFO bei OPTHEA LIMITED
Aktive Positionen von Peter F. Lang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OPTHEA LIMITED | Director of Finance/CFO | 27.10.2023 | - |
Karriereverlauf von Peter F. Lang
Ehemalige bekannte Positionen von Peter F. Lang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | 18.03.2022 | 21.11.2022 |
| Ridge Advisory LLC | Corporate Officer/Principal | - | - |
Ausbildung von Peter F. Lang
| The University of Chicago Booth School of Business | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Australien | 2 |
Operativ
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
| Ridge Advisory LLC |
- Börse
- Insiders
- Peter F. Lang
- Erfahrung
